nodes	percent_of_prediction	percent_of_DWPC	metapath
Altretamine—Peripheral sensory neuropathy—Crizotinib—lung cancer	0.0493	0.0493	CcSEcCtD
Altretamine—Peripheral sensory neuropathy—Pemetrexed—lung cancer	0.045	0.045	CcSEcCtD
Altretamine—Neurotoxicity—Teniposide—lung cancer	0.0269	0.0269	CcSEcCtD
Altretamine—Myelosuppression—Teniposide—lung cancer	0.0222	0.0222	CcSEcCtD
Altretamine—Ovarian cancer—Docetaxel—lung cancer	0.0217	0.0217	CcSEcCtD
Altretamine—Peripheral sensory neuropathy—Gemcitabine—lung cancer	0.0186	0.0186	CcSEcCtD
Altretamine—Neurotoxicity—Vinorelbine—lung cancer	0.017	0.017	CcSEcCtD
Altretamine—Myelosuppression—Vinblastine—lung cancer	0.017	0.017	CcSEcCtD
Altretamine—Myelosuppression—Topotecan—lung cancer	0.0165	0.0165	CcSEcCtD
Altretamine—Neurological symptom—Cisplatin—lung cancer	0.0164	0.0164	CcSEcCtD
Altretamine—Peripheral sensory neuropathy—Paclitaxel—lung cancer	0.0156	0.0156	CcSEcCtD
Altretamine—Neoplasm malignant—Pemetrexed—lung cancer	0.0151	0.0151	CcSEcCtD
Altretamine—Neurological symptom—Paclitaxel—lung cancer	0.0147	0.0147	CcSEcCtD
Altretamine—Myelosuppression—Vinorelbine—lung cancer	0.0141	0.0141	CcSEcCtD
Altretamine—Phosphatase alkaline increased—Crizotinib—lung cancer	0.0141	0.0141	CcSEcCtD
Altretamine—Neurotoxicity—Gemcitabine—lung cancer	0.0137	0.0137	CcSEcCtD
Altretamine—Neurotoxicity—Cisplatin—lung cancer	0.0128	0.0128	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Crizotinib—lung cancer	0.0117	0.0117	CcSEcCtD
Altretamine—Neurotoxicity—Etoposide—lung cancer	0.0117	0.0117	CcSEcCtD
Altretamine—Neurotoxicity—Paclitaxel—lung cancer	0.0115	0.0115	CcSEcCtD
Altretamine—Myelosuppression—Cisplatin—lung cancer	0.0106	0.0106	CcSEcCtD
Altretamine—Neurotoxicity—Docetaxel—lung cancer	0.00972	0.00972	CcSEcCtD
Altretamine—Myelosuppression—Etoposide—lung cancer	0.00967	0.00967	CcSEcCtD
Altretamine—Myelosuppression—Paclitaxel—lung cancer	0.00948	0.00948	CcSEcCtD
Altretamine—Neoplasm—Teniposide—lung cancer	0.00942	0.00942	CcSEcCtD
Altretamine—Peripheral sensory neuropathy—Doxorubicin—lung cancer	0.00823	0.00823	CcSEcCtD
Altretamine—Myelosuppression—Docetaxel—lung cancer	0.00803	0.00803	CcSEcCtD
Altretamine—Neuropathy peripheral—Crizotinib—lung cancer	0.00772	0.00772	CcSEcCtD
Altretamine—Pancytopenia—Pemetrexed—lung cancer	0.00767	0.00767	CcSEcCtD
Altretamine—Neoplasm—Vinblastine—lung cancer	0.00719	0.00719	CcSEcCtD
Altretamine—Neuropathy peripheral—Pemetrexed—lung cancer	0.00705	0.00705	CcSEcCtD
Altretamine—Neurotoxicity—Methotrexate—lung cancer	0.007	0.007	CcSEcCtD
Altretamine—Neoplasm—Topotecan—lung cancer	0.00698	0.00698	CcSEcCtD
Altretamine—Neoplasm malignant—Irinotecan—lung cancer	0.00638	0.00638	CcSEcCtD
Altretamine—Neoplasm malignant—Gemcitabine—lung cancer	0.00622	0.00622	CcSEcCtD
Altretamine—Pancytopenia—Teniposide—lung cancer	0.00621	0.00621	CcSEcCtD
Altretamine—Neurotoxicity—Doxorubicin—lung cancer	0.00606	0.00606	CcSEcCtD
Altretamine—Neuropathy peripheral—Teniposide—lung cancer	0.00571	0.00571	CcSEcCtD
Altretamine—Anaemia—Crizotinib—lung cancer	0.00569	0.00569	CcSEcCtD
Altretamine—Leukopenia—Crizotinib—lung cancer	0.00551	0.00551	CcSEcCtD
Altretamine—Phosphatase alkaline increased—Irinotecan—lung cancer	0.00545	0.00545	CcSEcCtD
Altretamine—Phosphatase alkaline increased—Gemcitabine—lung cancer	0.00531	0.00531	CcSEcCtD
Altretamine—Anaemia—Pemetrexed—lung cancer	0.0052	0.0052	CcSEcCtD
Altretamine—Anaemia—Gefitinib—lung cancer	0.00516	0.00516	CcSEcCtD
Altretamine—Leukopenia—Pemetrexed—lung cancer	0.00503	0.00503	CcSEcCtD
Altretamine—Myelosuppression—Doxorubicin—lung cancer	0.00501	0.00501	CcSEcCtD
Altretamine—Neoplasm—Irinotecan—lung cancer	0.00493	0.00493	CcSEcCtD
Altretamine—Pancytopenia—Vinblastine—lung cancer	0.00474	0.00474	CcSEcCtD
Altretamine—Pancytopenia—Topotecan—lung cancer	0.0046	0.0046	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Irinotecan—lung cancer	0.00455	0.00455	CcSEcCtD
Altretamine—Phosphatase alkaline increased—Etoposide—lung cancer	0.00453	0.00453	CcSEcCtD
Altretamine—Thrombocytopenia—Pemetrexed—lung cancer	0.00449	0.00449	CcSEcCtD
Altretamine—Thrombocytopenia—Gefitinib—lung cancer	0.00447	0.00447	CcSEcCtD
Altretamine—Phosphatase alkaline increased—Paclitaxel—lung cancer	0.00444	0.00444	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Gemcitabine—lung cancer	0.00443	0.00443	CcSEcCtD
Altretamine—Anorexia—Pemetrexed—lung cancer	0.00438	0.00438	CcSEcCtD
Altretamine—Decreased appetite—Crizotinib—lung cancer	0.00437	0.00437	CcSEcCtD
Altretamine—Neuropathy peripheral—Vinblastine—lung cancer	0.00436	0.00436	CcSEcCtD
Altretamine—Anorexia—Gefitinib—lung cancer	0.00435	0.00435	CcSEcCtD
Altretamine—Fatigue—Crizotinib—lung cancer	0.00433	0.00433	CcSEcCtD
Altretamine—Neuropathy peripheral—Topotecan—lung cancer	0.00424	0.00424	CcSEcCtD
Altretamine—Anaemia—Teniposide—lung cancer	0.00421	0.00421	CcSEcCtD
Altretamine—Neuropathy peripheral—Erlotinib—lung cancer	0.00419	0.00419	CcSEcCtD
Altretamine—Leukopenia—Teniposide—lung cancer	0.00408	0.00408	CcSEcCtD
Altretamine—Neoplasm—Paclitaxel—lung cancer	0.00402	0.00402	CcSEcCtD
Altretamine—Decreased appetite—Pemetrexed—lung cancer	0.00399	0.00399	CcSEcCtD
Altretamine—Decreased appetite—Gefitinib—lung cancer	0.00396	0.00396	CcSEcCtD
Altretamine—Fatigue—Pemetrexed—lung cancer	0.00396	0.00396	CcSEcCtD
Altretamine—Pancytopenia—Vinorelbine—lung cancer	0.00394	0.00394	CcSEcCtD
Altretamine—Fatigue—Gefitinib—lung cancer	0.00393	0.00393	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Etoposide—lung cancer	0.00378	0.00378	CcSEcCtD
Altretamine—Phosphatase alkaline increased—Docetaxel—lung cancer	0.00377	0.00377	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Paclitaxel—lung cancer	0.00371	0.00371	CcSEcCtD
Altretamine—Thrombocytopenia—Teniposide—lung cancer	0.00364	0.00364	CcSEcCtD
Altretamine—Neuropathy peripheral—Vinorelbine—lung cancer	0.00362	0.00362	CcSEcCtD
Altretamine—Asthenia—Crizotinib—lung cancer	0.0036	0.0036	CcSEcCtD
Altretamine—Anorexia—Teniposide—lung cancer	0.00354	0.00354	CcSEcCtD
Altretamine—Neoplasm—Docetaxel—lung cancer	0.00341	0.00341	CcSEcCtD
Altretamine—Dizziness—Crizotinib—lung cancer	0.00332	0.00332	CcSEcCtD
Altretamine—Asthenia—Pemetrexed—lung cancer	0.00329	0.00329	CcSEcCtD
Altretamine—Asthenia—Gefitinib—lung cancer	0.00327	0.00327	CcSEcCtD
Altretamine—Decreased appetite—Teniposide—lung cancer	0.00323	0.00323	CcSEcCtD
Altretamine—Anaemia—Vinblastine—lung cancer	0.00321	0.00321	CcSEcCtD
Altretamine—Vomiting—Crizotinib—lung cancer	0.00319	0.00319	CcSEcCtD
Altretamine—Pancytopenia—Gemcitabine—lung cancer	0.00316	0.00316	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Docetaxel—lung cancer	0.00314	0.00314	CcSEcCtD
Altretamine—Vertigo—Vinblastine—lung cancer	0.00312	0.00312	CcSEcCtD
Altretamine—Anaemia—Topotecan—lung cancer	0.00312	0.00312	CcSEcCtD
Altretamine—Leukopenia—Vinblastine—lung cancer	0.00311	0.00311	CcSEcCtD
Altretamine—Dizziness—Pemetrexed—lung cancer	0.00304	0.00304	CcSEcCtD
Altretamine—Ataxia—Paclitaxel—lung cancer	0.00303	0.00303	CcSEcCtD
Altretamine—Leukopenia—Topotecan—lung cancer	0.00302	0.00302	CcSEcCtD
Altretamine—Convulsion—Vinblastine—lung cancer	0.00301	0.00301	CcSEcCtD
Altretamine—Nausea—Crizotinib—lung cancer	0.00298	0.00298	CcSEcCtD
Altretamine—Pancytopenia—Cisplatin—lung cancer	0.00295	0.00295	CcSEcCtD
Altretamine—Vomiting—Pemetrexed—lung cancer	0.00292	0.00292	CcSEcCtD
Altretamine—Neuropathy peripheral—Gemcitabine—lung cancer	0.00291	0.00291	CcSEcCtD
Altretamine—Vomiting—Gefitinib—lung cancer	0.0029	0.0029	CcSEcCtD
Altretamine—Thrombocytopenia—Vinblastine—lung cancer	0.00278	0.00278	CcSEcCtD
Altretamine—Neoplasm malignant—Doxorubicin—lung cancer	0.00275	0.00275	CcSEcCtD
Altretamine—Nausea—Pemetrexed—lung cancer	0.00273	0.00273	CcSEcCtD
Altretamine—Neuropathy peripheral—Cisplatin—lung cancer	0.00271	0.00271	CcSEcCtD
Altretamine—Nausea—Gefitinib—lung cancer	0.00271	0.00271	CcSEcCtD
Altretamine—Anorexia—Vinblastine—lung cancer	0.0027	0.0027	CcSEcCtD
Altretamine—Pancytopenia—Etoposide—lung cancer	0.0027	0.0027	CcSEcCtD
Altretamine—Thrombocytopenia—Topotecan—lung cancer	0.0027	0.0027	CcSEcCtD
Altretamine—Anaemia—Vinorelbine—lung cancer	0.00267	0.00267	CcSEcCtD
Altretamine—Thrombocytopenia—Erlotinib—lung cancer	0.00267	0.00267	CcSEcCtD
Altretamine—Asthenia—Teniposide—lung cancer	0.00267	0.00267	CcSEcCtD
Altretamine—Pancytopenia—Paclitaxel—lung cancer	0.00265	0.00265	CcSEcCtD
Altretamine—Anorexia—Topotecan—lung cancer	0.00263	0.00263	CcSEcCtD
Altretamine—Anorexia—Erlotinib—lung cancer	0.0026	0.0026	CcSEcCtD
Altretamine—Vertigo—Vinorelbine—lung cancer	0.0026	0.0026	CcSEcCtD
Altretamine—Leukopenia—Vinorelbine—lung cancer	0.00259	0.00259	CcSEcCtD
Altretamine—Ataxia—Docetaxel—lung cancer	0.00257	0.00257	CcSEcCtD
Altretamine—Neuropathy peripheral—Etoposide—lung cancer	0.00249	0.00249	CcSEcCtD
Altretamine—Decreased appetite—Vinblastine—lung cancer	0.00247	0.00247	CcSEcCtD
Altretamine—Neoplasm—Methotrexate—lung cancer	0.00245	0.00245	CcSEcCtD
Altretamine—Neuropathy peripheral—Paclitaxel—lung cancer	0.00244	0.00244	CcSEcCtD
Altretamine—Decreased appetite—Topotecan—lung cancer	0.0024	0.0024	CcSEcCtD
Altretamine—Fatigue—Topotecan—lung cancer	0.00238	0.00238	CcSEcCtD
Altretamine—Decreased appetite—Erlotinib—lung cancer	0.00237	0.00237	CcSEcCtD
Altretamine—Vomiting—Teniposide—lung cancer	0.00236	0.00236	CcSEcCtD
Altretamine—Phosphatase alkaline increased—Doxorubicin—lung cancer	0.00235	0.00235	CcSEcCtD
Altretamine—Fatigue—Erlotinib—lung cancer	0.00235	0.00235	CcSEcCtD
Altretamine—Thrombocytopenia—Vinorelbine—lung cancer	0.00231	0.00231	CcSEcCtD
Altretamine—Anorexia—Vinorelbine—lung cancer	0.00225	0.00225	CcSEcCtD
Altretamine—Pancytopenia—Docetaxel—lung cancer	0.00224	0.00224	CcSEcCtD
Altretamine—Nausea—Teniposide—lung cancer	0.00221	0.00221	CcSEcCtD
Altretamine—Anaemia—Irinotecan—lung cancer	0.0022	0.0022	CcSEcCtD
Altretamine—Anaemia—Gemcitabine—lung cancer	0.00214	0.00214	CcSEcCtD
Altretamine—Vertigo—Irinotecan—lung cancer	0.00214	0.00214	CcSEcCtD
Altretamine—Leukopenia—Irinotecan—lung cancer	0.00213	0.00213	CcSEcCtD
Altretamine—Neoplasm—Doxorubicin—lung cancer	0.00213	0.00213	CcSEcCtD
Altretamine—Leukopenia—Gemcitabine—lung cancer	0.00208	0.00208	CcSEcCtD
Altretamine—Neuropathy peripheral—Docetaxel—lung cancer	0.00207	0.00207	CcSEcCtD
Altretamine—Decreased appetite—Vinorelbine—lung cancer	0.00205	0.00205	CcSEcCtD
Altretamine—Asthenia—Vinblastine—lung cancer	0.00204	0.00204	CcSEcCtD
Altretamine—Fatigue—Vinorelbine—lung cancer	0.00203	0.00203	CcSEcCtD
Altretamine—Anaemia—Cisplatin—lung cancer	0.002	0.002	CcSEcCtD
Altretamine—Asthenia—Topotecan—lung cancer	0.00198	0.00198	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Doxorubicin—lung cancer	0.00196	0.00196	CcSEcCtD
Altretamine—Asthenia—Erlotinib—lung cancer	0.00196	0.00196	CcSEcCtD
Altretamine—Leukopenia—Cisplatin—lung cancer	0.00194	0.00194	CcSEcCtD
Altretamine—Thrombocytopenia—Irinotecan—lung cancer	0.0019	0.0019	CcSEcCtD
Altretamine—Dizziness—Vinblastine—lung cancer	0.00188	0.00188	CcSEcCtD
Altretamine—Convulsion—Cisplatin—lung cancer	0.00187	0.00187	CcSEcCtD
Altretamine—Thrombocytopenia—Gemcitabine—lung cancer	0.00185	0.00185	CcSEcCtD
Altretamine—Anorexia—Irinotecan—lung cancer	0.00185	0.00185	CcSEcCtD
Altretamine—Ataxia—Methotrexate—lung cancer	0.00185	0.00185	CcSEcCtD
Altretamine—Anaemia—Etoposide—lung cancer	0.00183	0.00183	CcSEcCtD
Altretamine—Dizziness—Topotecan—lung cancer	0.00182	0.00182	CcSEcCtD
Altretamine—Anorexia—Gemcitabine—lung cancer	0.00181	0.00181	CcSEcCtD
Altretamine—Vomiting—Vinblastine—lung cancer	0.0018	0.0018	CcSEcCtD
Altretamine—Dizziness—Erlotinib—lung cancer	0.0018	0.0018	CcSEcCtD
Altretamine—Anaemia—Paclitaxel—lung cancer	0.0018	0.0018	CcSEcCtD
Altretamine—Vertigo—Etoposide—lung cancer	0.00178	0.00178	CcSEcCtD
Altretamine—Leukopenia—Etoposide—lung cancer	0.00177	0.00177	CcSEcCtD
Altretamine—Vomiting—Topotecan—lung cancer	0.00175	0.00175	CcSEcCtD
Altretamine—Vertigo—Paclitaxel—lung cancer	0.00175	0.00175	CcSEcCtD
Altretamine—Leukopenia—Paclitaxel—lung cancer	0.00174	0.00174	CcSEcCtD
Altretamine—Vomiting—Erlotinib—lung cancer	0.00173	0.00173	CcSEcCtD
Altretamine—Thrombocytopenia—Cisplatin—lung cancer	0.00173	0.00173	CcSEcCtD
Altretamine—Convulsion—Etoposide—lung cancer	0.00172	0.00172	CcSEcCtD
Altretamine—Asthenia—Vinorelbine—lung cancer	0.00169	0.00169	CcSEcCtD
Altretamine—Decreased appetite—Irinotecan—lung cancer	0.00169	0.00169	CcSEcCtD
Altretamine—Nausea—Vinblastine—lung cancer	0.00168	0.00168	CcSEcCtD
Altretamine—Convulsion—Paclitaxel—lung cancer	0.00168	0.00168	CcSEcCtD
Altretamine—Anorexia—Cisplatin—lung cancer	0.00168	0.00168	CcSEcCtD
Altretamine—Fatigue—Irinotecan—lung cancer	0.00168	0.00168	CcSEcCtD
Altretamine—Decreased appetite—Gemcitabine—lung cancer	0.00165	0.00165	CcSEcCtD
Altretamine—Nausea—Topotecan—lung cancer	0.00164	0.00164	CcSEcCtD
Altretamine—Fatigue—Gemcitabine—lung cancer	0.00163	0.00163	CcSEcCtD
Altretamine—Nausea—Erlotinib—lung cancer	0.00162	0.00162	CcSEcCtD
Altretamine—Pancytopenia—Methotrexate—lung cancer	0.00162	0.00162	CcSEcCtD
Altretamine—Ataxia—Doxorubicin—lung cancer	0.0016	0.0016	CcSEcCtD
Altretamine—Thrombocytopenia—Etoposide—lung cancer	0.00158	0.00158	CcSEcCtD
Altretamine—Dizziness—Vinorelbine—lung cancer	0.00156	0.00156	CcSEcCtD
Altretamine—Thrombocytopenia—Paclitaxel—lung cancer	0.00155	0.00155	CcSEcCtD
Altretamine—Anorexia—Etoposide—lung cancer	0.00154	0.00154	CcSEcCtD
Altretamine—Decreased appetite—Cisplatin—lung cancer	0.00153	0.00153	CcSEcCtD
Altretamine—Anaemia—Docetaxel—lung cancer	0.00152	0.00152	CcSEcCtD
Altretamine—Anorexia—Paclitaxel—lung cancer	0.00151	0.00151	CcSEcCtD
Altretamine—Vomiting—Vinorelbine—lung cancer	0.0015	0.0015	CcSEcCtD
Altretamine—Leukopenia—Docetaxel—lung cancer	0.00147	0.00147	CcSEcCtD
Altretamine—Convulsion—Docetaxel—lung cancer	0.00143	0.00143	CcSEcCtD
Altretamine—Decreased appetite—Etoposide—lung cancer	0.00141	0.00141	CcSEcCtD
Altretamine—Pancytopenia—Doxorubicin—lung cancer	0.0014	0.0014	CcSEcCtD
Altretamine—Nausea—Vinorelbine—lung cancer	0.0014	0.0014	CcSEcCtD
Altretamine—Asthenia—Irinotecan—lung cancer	0.00139	0.00139	CcSEcCtD
Altretamine—Fatigue—Etoposide—lung cancer	0.00139	0.00139	CcSEcCtD
Altretamine—Decreased appetite—Paclitaxel—lung cancer	0.00138	0.00138	CcSEcCtD
Altretamine—Fatigue—Paclitaxel—lung cancer	0.00137	0.00137	CcSEcCtD
Altretamine—Asthenia—Gemcitabine—lung cancer	0.00136	0.00136	CcSEcCtD
Altretamine—Thrombocytopenia—Docetaxel—lung cancer	0.00132	0.00132	CcSEcCtD
Altretamine—Neuropathy peripheral—Doxorubicin—lung cancer	0.00129	0.00129	CcSEcCtD
Altretamine—Dizziness—Irinotecan—lung cancer	0.00129	0.00129	CcSEcCtD
Altretamine—Anorexia—Docetaxel—lung cancer	0.00128	0.00128	CcSEcCtD
Altretamine—Asthenia—Cisplatin—lung cancer	0.00127	0.00127	CcSEcCtD
Altretamine—Vomiting—Irinotecan—lung cancer	0.00124	0.00124	CcSEcCtD
Altretamine—Vomiting—Gemcitabine—lung cancer	0.0012	0.0012	CcSEcCtD
Altretamine—Decreased appetite—Docetaxel—lung cancer	0.00117	0.00117	CcSEcCtD
Altretamine—Asthenia—Etoposide—lung cancer	0.00116	0.00116	CcSEcCtD
Altretamine—Fatigue—Docetaxel—lung cancer	0.00116	0.00116	CcSEcCtD
Altretamine—Nausea—Irinotecan—lung cancer	0.00115	0.00115	CcSEcCtD
Altretamine—Asthenia—Paclitaxel—lung cancer	0.00114	0.00114	CcSEcCtD
Altretamine—Nausea—Gemcitabine—lung cancer	0.00112	0.00112	CcSEcCtD
Altretamine—Vomiting—Cisplatin—lung cancer	0.00112	0.00112	CcSEcCtD
Altretamine—Anaemia—Methotrexate—lung cancer	0.0011	0.0011	CcSEcCtD
Altretamine—Dizziness—Etoposide—lung cancer	0.00107	0.00107	CcSEcCtD
Altretamine—Vertigo—Methotrexate—lung cancer	0.00107	0.00107	CcSEcCtD
Altretamine—Leukopenia—Methotrexate—lung cancer	0.00106	0.00106	CcSEcCtD
Altretamine—Dizziness—Paclitaxel—lung cancer	0.00105	0.00105	CcSEcCtD
Altretamine—Nausea—Cisplatin—lung cancer	0.00105	0.00105	CcSEcCtD
Altretamine—Convulsion—Methotrexate—lung cancer	0.00103	0.00103	CcSEcCtD
Altretamine—Vomiting—Etoposide—lung cancer	0.00103	0.00103	CcSEcCtD
Altretamine—Vomiting—Paclitaxel—lung cancer	0.00101	0.00101	CcSEcCtD
Altretamine—Asthenia—Docetaxel—lung cancer	0.000964	0.000964	CcSEcCtD
Altretamine—Nausea—Etoposide—lung cancer	0.000961	0.000961	CcSEcCtD
Altretamine—Anaemia—Doxorubicin—lung cancer	0.00095	0.00095	CcSEcCtD
Altretamine—Thrombocytopenia—Methotrexate—lung cancer	0.000948	0.000948	CcSEcCtD
Altretamine—Nausea—Paclitaxel—lung cancer	0.000942	0.000942	CcSEcCtD
Altretamine—Vertigo—Doxorubicin—lung cancer	0.000923	0.000923	CcSEcCtD
Altretamine—Anorexia—Methotrexate—lung cancer	0.000923	0.000923	CcSEcCtD
Altretamine—Leukopenia—Doxorubicin—lung cancer	0.00092	0.00092	CcSEcCtD
Altretamine—Convulsion—Doxorubicin—lung cancer	0.00089	0.00089	CcSEcCtD
Altretamine—Dizziness—Docetaxel—lung cancer	0.000889	0.000889	CcSEcCtD
Altretamine—Vomiting—Docetaxel—lung cancer	0.000854	0.000854	CcSEcCtD
Altretamine—Decreased appetite—Methotrexate—lung cancer	0.000842	0.000842	CcSEcCtD
Altretamine—Fatigue—Methotrexate—lung cancer	0.000835	0.000835	CcSEcCtD
Altretamine—Thrombocytopenia—Doxorubicin—lung cancer	0.000821	0.000821	CcSEcCtD
Altretamine—Anorexia—Doxorubicin—lung cancer	0.000799	0.000799	CcSEcCtD
Altretamine—Nausea—Docetaxel—lung cancer	0.000798	0.000798	CcSEcCtD
Altretamine—Decreased appetite—Doxorubicin—lung cancer	0.000729	0.000729	CcSEcCtD
Altretamine—Fatigue—Doxorubicin—lung cancer	0.000723	0.000723	CcSEcCtD
Altretamine—Asthenia—Methotrexate—lung cancer	0.000695	0.000695	CcSEcCtD
Altretamine—Dizziness—Methotrexate—lung cancer	0.000641	0.000641	CcSEcCtD
Altretamine—Vomiting—Methotrexate—lung cancer	0.000616	0.000616	CcSEcCtD
Altretamine—Asthenia—Doxorubicin—lung cancer	0.000602	0.000602	CcSEcCtD
Altretamine—Nausea—Methotrexate—lung cancer	0.000575	0.000575	CcSEcCtD
Altretamine—Dizziness—Doxorubicin—lung cancer	0.000555	0.000555	CcSEcCtD
Altretamine—Vomiting—Doxorubicin—lung cancer	0.000533	0.000533	CcSEcCtD
Altretamine—Nausea—Doxorubicin—lung cancer	0.000498	0.000498	CcSEcCtD
